{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T14:18:54Z","timestamp":1770819534010,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81570190"],"award-info":[{"award-number":["81570190"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81670194"],"award-info":[{"award-number":["81670194"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81602515"],"award-info":[{"award-number":["81602515"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81372391"],"award-info":[{"award-number":["81372391"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.canlet.2018.12.014","type":"journal-article","created":{"date-parts":[[2018,12,21]],"date-time":"2018-12-21T19:47:14Z","timestamp":1545421634000},"page":"45-59","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Rafoxanide, an organohalogen drug, triggers apoptosis and cell cycle arrest in multiple myeloma by enhancing DNA damage responses and suppressing the p38 MAPK pathway"],"prefix":"10.1016","volume":"444","author":[{"given":"Wenqin","family":"Xiao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhijian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuaikang","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dandan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huiqun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongsheng","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingcong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bingqian","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanyuan","family":"Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiucai","family":"Lan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenxuan","family":"Bu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gege","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaosong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8553-4559","authenticated-orcid":false,"given":"Jumei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiliang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2018.12.014_bib1","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1056\/NEJMra041875","article-title":"Multiple myeloma","volume":"351","author":"Kyle","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2018.12.014_bib2","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1182\/blood-2007-10-078022","article-title":"Multiple myeloma","volume":"111","author":"Kyle","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2018.12.014_bib3","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/leu.2013.293","article-title":"International Myeloma Working Group recommendations for global myeloma care","volume":"28","author":"Ludwig","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.canlet.2018.12.014_bib4","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1182\/blood-2007-10-116129","article-title":"Improved survival in multiple myeloma and the impact of novel therapies","volume":"111","author":"Kumar","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2018.12.014_bib5","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1182\/blood-2016-02-698092","article-title":"Targeted sequencing of refractory myeloma reveals a high incidence of mutations in CRBN and Ras pathway genes","volume":"128","author":"Kortum","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2018.12.014_bib6","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3109\/03602538708998307","article-title":"The metabolism and fate of closantel (Flukiver) in sheep and cattle","volume":"18","author":"Michiels","year":"1987","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.canlet.2018.12.014_bib7","first-page":"851","article-title":"Closantel, a new antiparasitic hydrogen ionophore [proceedings]","volume":"87","author":"Van Den Bossche","year":"1979","journal-title":"Arch. Int. Physiol. Biochim."},{"key":"10.1016\/j.canlet.2018.12.014_bib8","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.toxlet.2011.10.004","article-title":"An improved thyroid hormone reporter assay to determine the thyroid hormone-like activity of amiodarone, bithionol, closantel and rafoxanide","volume":"208","author":"Matsubara","year":"2012","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.canlet.2018.12.014_bib9","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/cmdc.201700077","article-title":"Rafoxanide and closantel inhibit SPAK and OSR1 kinases by binding to a highly conserved allosteric site on their C-terminal domains","volume":"12","author":"AlAmri","year":"2017","journal-title":"ChemMedChem"},{"key":"10.1016\/j.canlet.2018.12.014_bib10","first-page":"38","article-title":"Rafanoxide therapy in a child with fascioliasis","volume":"19","author":"Yurdakok","year":"1985","journal-title":"Mikrobiyol. Bul."},{"key":"10.1016\/j.canlet.2018.12.014_bib11","doi-asserted-by":"crossref","first-page":"33642","DOI":"10.1038\/srep33642","article-title":"Reprofiled anthelmintics abate hypervirulent stationary-phase Clostridium difficile","volume":"6","author":"Gooyit","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2018.12.014_bib12","doi-asserted-by":"crossref","first-page":"31074","DOI":"10.1038\/srep31074","article-title":"Repositioning organohalogen drugs: a case study for identification of potent B-Raf V600E inhibitors via docking and bioassay","volume":"6","author":"Li","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2018.12.014_bib13","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1158\/2159-8290.CD-13-0297","article-title":"Targeting BRAF in multiple myeloma","volume":"3","author":"O'Donnell","year":"2013","journal-title":"Cancer Discov."},{"key":"10.1016\/j.canlet.2018.12.014_bib14","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1158\/2159-8290.CD-13-0014","article-title":"Targeting the BRAF V600E mutation in multiple myeloma","volume":"3","author":"Andrulis","year":"2013","journal-title":"Cancer Discov."},{"key":"10.1016\/j.canlet.2018.12.014_bib15","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1002\/hon.2353","article-title":"Vemurafenib in combination with cobimetinib in relapsed and refractory extramedullary multiple myeloma harboring the BRAF V600E mutation","volume":"35","author":"Mey","year":"2017","journal-title":"Hematol. Oncol."},{"key":"10.1016\/j.canlet.2018.12.014_bib16","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.bbamcr.2006.10.001","article-title":"Roles of the Raf\/MEK\/ERK pathway in cell growth, malignant transformation and drug resistance","volume":"1773","author":"McCubrey","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.canlet.2018.12.014_bib17","doi-asserted-by":"crossref","first-page":"3712","DOI":"10.1182\/blood.V82.12.3712.3712","article-title":"Adhesion of human myeloma-derived cell lines to bone marrow stromal cells stimulates interleukin-6 secretion","volume":"82","author":"Uchiyama","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2018.12.014_bib18","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/nrc2189","article-title":"Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targets","volume":"7","author":"Hideshima","year":"2007","journal-title":"Nat. Rev. Canc."},{"key":"10.1016\/j.canlet.2018.12.014_bib19","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.jpba.2006.03.022","article-title":"Voltammetric assay of the anthelmintic veterinary drug nitroxynil in bulk form and formulation at a mercury electrode","volume":"41","author":"Ghoneim","year":"2006","journal-title":"J. Pharmaceut. Biomed. Anal."},{"key":"10.1016\/j.canlet.2018.12.014_bib20","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1038\/leu.2017.173","article-title":"Pomalidomide, bortezomib and low-dose dexamethasone in lenalidomide-refractory and proteasome inhibitor-exposed myeloma","volume":"31","author":"Richardson","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.canlet.2018.12.014_bib21","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1158\/1078-0432.CCR-10-3366","article-title":"Oncogenomics to target myeloma in the bone marrow microenvironment","volume":"17","author":"Anderson","year":"2011","journal-title":"Clin. Canc. Res. : Official J. Am. Assoc. Canc. Res."},{"key":"10.1016\/j.canlet.2018.12.014_bib22","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1182\/blood-2016-10-745059","article-title":"Bone marrow microenvironment-derived signals induce Mcl-1 dependence in multiple myeloma","volume":"129","author":"Gupta","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2018.12.014_bib23","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1476-4598-9-47","article-title":"Sulforaphane induces cell cycle arrest by protecting RB-E2F-1 complex in epithelial ovarian cancer cells","volume":"9","author":"Bryant","year":"2010","journal-title":"Mol. Canc."},{"key":"10.1016\/j.canlet.2018.12.014_bib24","doi-asserted-by":"crossref","first-page":"e3015","DOI":"10.1038\/cddis.2017.422","article-title":"Apatinib promotes autophagy and apoptosis through VEGFR2\/STAT3\/BCL-2 signaling in osteosarcoma","volume":"8","author":"Liu","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2018.12.014_bib25","doi-asserted-by":"crossref","first-page":"8471","DOI":"10.1007\/s13277-016-5035-9","article-title":"Major apoptotic mechanisms and genes involved in apoptosis","volume":"37","author":"Kiraz","year":"2016","journal-title":"Tumour Biol. : J. Int. Soc. Oncodev. Biol. Med."},{"key":"10.1016\/j.canlet.2018.12.014_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17111927","article-title":"Pterostilbene inhibits human multiple myeloma cells via ERK1\/2 and JNK pathway in vitro and in vivo","volume":"17","author":"Xie","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2018.12.014_bib27","doi-asserted-by":"crossref","first-page":"5202","DOI":"10.1182\/blood-2009-12-259523","article-title":"A novel Aurora-A kinase inhibitor MLN8237 induces cytotoxicity and cell-cycle arrest in multiple myeloma","volume":"115","author":"Gorgun","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2018.12.014_bib28","first-page":"629","article-title":"Mahanine, a novel mitochondrial complex-III inhibitor induces G0\/G1 arrest through redox alteration-mediated DNA damage response and regresses glioblastoma multiforme","volume":"4","author":"Bhattacharya","year":"2014","journal-title":"Am. J. Canc. Res."},{"key":"10.1016\/j.canlet.2018.12.014_bib29","doi-asserted-by":"crossref","first-page":"14927","DOI":"10.1074\/jbc.M115.658419","article-title":"PNAS-4, an early DNA damage response gene, induces S phase Arrest and apoptosis by activating checkpoint kinases in lung cancer cells","volume":"290","author":"Yuan","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2018.12.014_bib30","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1038\/leu.2011.94","article-title":"Evidence for ongoing DNA damage in multiple myeloma cells as revealed by constitutive phosphorylation of H2AX","volume":"25","author":"Walters","year":"2011","journal-title":"Leukemia"},{"key":"10.1016\/j.canlet.2018.12.014_bib31","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1182\/blood-2008-05-159392","article-title":"Interruption of the Ras\/MEK\/ERK signaling cascade enhances Chk1 inhibitor-induced DNA damage in vitro and in vivo in human multiple myeloma cells","volume":"112","author":"Dai","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2018.12.014_bib32","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.canlet.2011.05.018","article-title":"Astragalin heptaacetate-induced cell death in human leukemia cells is dependent on caspases and activates the MAPK pathway","volume":"309","author":"Burmistrova","year":"2011","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2018.12.014_bib33","doi-asserted-by":"crossref","first-page":"3789","DOI":"10.1038\/onc.2012.556","article-title":"Various modes of cell death induced by DNA damage","volume":"32","author":"Surova","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2018.12.014_bib34","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0079-6107(98)00056-X","article-title":"MAP kinase pathways","volume":"71","author":"Cobb","year":"1999","journal-title":"Prog. Biophys. Mol. Biol."},{"key":"10.1016\/j.canlet.2018.12.014_bib35","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s12943-017-0684-x","article-title":"PLX8394, a new generation BRAF inhibitor, selectively inhibits BRAF in colonic adenocarcinoma cells and prevents paradoxical MAPK pathway activation","volume":"16","author":"Tutuka","year":"2017","journal-title":"Mol. Canc."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383518307298?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383518307298?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,11,12]],"date-time":"2019-11-12T18:00:36Z","timestamp":1573581636000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383518307298"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":35,"alternative-id":["S0304383518307298"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2018.12.014","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rafoxanide, an organohalogen drug, triggers apoptosis and cell cycle arrest in multiple myeloma by enhancing DNA damage responses and suppressing the p38 MAPK pathway","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2018.12.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}